-
Sector Analysis
Singapore Insurance Industry – Governance, Risk and Compliance
Singapore Insurance Industry Regulation Overview The MAS is the government authority responsible for the regulation and supervision of financial sectors in Singapore including the insurance industry. The MAS began regulating the insurance industry in April 1977 after it was established in 1970 under the Monetary Authority of Singapore Act 1970, enacted on December 26, 1970, and revised in 1999. The Singapore insurance industry governance regulation research report provides a detailed analysis of the regulations for several insurance types including life,...
-
Government & Regulation
South Africa Insurance Industry – Governance, Risk and Compliance
South Africa Insurance Industry Regulation Overview Twin Peaks Model is a new financial regulatory system that governs the insurance industry in South Africa. It is a comprehensive and complete model for regulating the financial sector in South Africa. Furthermore, the PA was established under the Reserve Bank of South Africa under the FSR Act 2017. It does not function as a public agency and is the prudential regulator responsible for the general administration, safety, and soundness of all financial institutions...
-
Government & Regulation
Hong Kong Insurance Industry – Governance, Risk and Compliance
Hong Kong Insurance Industry Regulation Overview The IA is the regulator of the insurance industry in Hong Kong. The Commissioner of Insurance heads and plays a chief role in the IA. It is responsible for administering and supervising insurers and insurance intermediaries to protect and promote the insurance industry. The Hong Kong insurance industry governance regulation research report provides a detailed analysis of the regulations for several insurance types including life, property, motor, and liability. The report also gives insights...
-
Government & Regulation
South Korea Insurance Industry – Governance, Risk and Compliance
South Korea Insurance Industry Regulation Overview The Financial Services Commission (FSC) and the Financial Supervisory Service (FSS) regulate the Spain insurance industry along with other regulators and supervisors, including the International Regulatory Authority (IAIS), Korea Life Insurance Association (KLIA), and the General Insurance Association of Korea (GIAK). The South Korean insurance industry governance regulation research report provides a detailed analysis of the regulations for several insurance types including life, property, motor, and liability. The report also gives insights into recent...
-
Government & Regulation
Israel Insurance Industry – Governance, Risk and Compliance
Israel Insurance Industry Regulation Overview The Israel insurance industry is supervised and regulated by the Capital Markets, Insurance and Savings Authority (CMISA) under the Ministry of Finance (MOF). The CMISA supervises the insurance industry according to Israeli insurance law, regulations, circulars, and instructions. The Israel insurance industry governance regulation research report provides a detailed analysis of the insurance regulations for life, property, motor, liability, personal accident, and health, and marine, aviation, and transit insurance. The report specifies various requirements for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Medulloblastoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Medulloblastoma Drug Details: Temozolomide (ORP-005) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Rhabdomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Rhabdomyosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Rhabdomyosarcoma Drug Details: Temozolomide (ORP-005) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Pediatric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Pediatric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Pediatric Cancer Drug Details: Temozolomide (ORP-005) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Ewing Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Ewing Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Ewing Sarcoma Drug Details: Temozolomide (ORP-005) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temozolomide in Anaplastic Astrocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temozolomide in Anaplastic Astrocytoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temozolomide in Anaplastic Astrocytoma Drug Details: Temozolomide (ORP-005) is under development...